Seekyo SAS

https://www.seekyo-therapeutics.com

Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies. By targeting the microenvironment of solid tumors while sparing healthy tissues, its aim is to provide efficient treatments without adverse effects to cancer patients. Thanks to its technology, Seekyo’s Smart Drugs are designed to transport potent anticancer agents in an innocuous manner towards safe tissues, recognize specificities of the tumor microenvironment and release the active drug in a stringently controlled fashion following an enzymatic activation. Founded in 2018, the company is based in Poitiers, France. *

	Start	2018-06-15 established
	Industry	BIOTECH
	Industry 2	vector (biotech)
	Person	Chetboun, Oury (Seekyo 201806– CEO + Co-Founder)
	Person 2	Papot, Sébastian (Univ Poitiers 202001 Prof + Seekyo 201806– CSO + Co-Founder)

	Region	Poitiers
	Country	France
	Street	4 rue Carol Heinz
	City	86000 Poitiers
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Seekyo SAS. (1/20/20). "Press Release: Biotech Start-up Seekyo Raises €800k with Leverage from French Tech Seed Fund". Poitiers.

		Record changed: 2025-03-16